The antibody response magnitude and kinetics may impact clinical severity, serological
diagnosis and long-term protection of COVID-19, which may play a role in why children …

There is limited understanding of the viral antibody fingerprint following severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. Herein, SARS-CoV …

The SARS-CoV-2 virus emerged in December 2019 and has caused a worldwide pandemic
due to the lack of any pre-existing immunity. Accurate serology testing is urgently needed to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel beta-coronavirus
that has emerged and caused a global pandemic of coronavirus disease 2019 (COVID-19) …

The immunogenicity of the SARS-CoV-2 proteome is largely unknown, especially for non-
structural proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and …

The search for potential antibody-based diagnostics, vaccines, and therapeutics for
pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has focused …

There is limited understanding of antibody responses in children across different SARS-CoV-
2 variants. As part of an ongoing household cohort study, we assessed the antibody …

A major goal of current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine efforts is to elicit antibody responses that confer protection. Mapping the epitope …

Abstract Background The SARS-CoV-2 virus emerged in December 2019 and caused a
pandemic associated with a spectrum of COVID-19 disease ranging from asymptomatic to …

Viruses use many different strategies to evade host immune responses. In the case of SARS-
CoV-2, its Spike mutates rapidly to escape from neutralizing antibodies. In addition to this …